Chunxiang Chai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chunxiang Chai has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Cuihong Li
1 shared publication- Donghua Xu
Center of Medical Research, Weifang People’s Hospital, Shandong Second Medical University
1 shared publication Guohong Gao
Department of Ophthalmology, The Affiliated Hospital of Weifang Medical University, Clinical Medical Institute Weifang Medical University Weifang China
1 shared publicationMin Cheng
Department of Physiology Weifang Medical University Weifang China
1 shared publicationNa Su
1 shared publicationQiongna Liu
1 shared publication
Latest Publications
- 28 May 2018
- Published by Wiley in Journal of Cellular Physiology
- Vol. 233 (11) , 8815-8825
Key genes and functional coexpression modules involved in the pathogenesis of systemic lupus erythematosus
We performed a systematic review of genome‐wide gene expression datasets to identify key genes and functional modules involved in the pathogenesis of systemic lupus erythematosus (SLE) at a systems level. Genome‐wide gene expression datasets involving SLE patients were searched in Gene Expression Omnibus and ArrayExpress databases. Robust rank aggregation (RRA) analysis was used to integrate those public datasets and identify key genes associated with SLE. The weighted gene coexpression network analysis (WGCNA) was adapted to identify functional modules involved in SLE pathogenesis, and the gene ontology enrichment analysis was utilized to explore their functions. The aberrant expressions of several randomly selected key genes were further validated in SLE patients through quantitative real‐time polymerase chain reaction. Fifteen genome‐wide gene expression datasets were finally included, which involved a total of 1,778 SLE patients and 408 healthy controls. A large number of significantly upregulated or downregulated genes were identified through RRA analysis, and some of those genes were novel SLE gene signatures and their molecular roles in etiology of SLE remained vague. WGCNA further successfully identified six main functional modules involved in the pathogenesis of SLE. The most important functional module involved in SLE included 182 genes and mainly enriched in biological processes, including defense response to virus, interferon signaling pathway, and cytokine‐mediated signaling pathway. This study identifies a number of key genes and functional coexpression modules involved in SLE, which provides deepening insights into the molecular mechanism of SLE at a systems level and also provides some promising therapeutic targets.
- 28 May 2018
- Published by Wiley in Journal of Cellular Physiology
- Vol. 233 (11) , 8815-8825
Key genes and functional coexpression modules involved in the pathogenesis of systemic lupus erythematosus
We performed a systematic review of genome‐wide gene expression datasets to identify key genes and functional modules involved in the pathogenesis of systemic lupus erythematosus (SLE) at a systems level. Genome‐wide gene expression datasets involving SLE patients were searched in Gene Expression Omnibus and ArrayExpress databases. Robust rank aggregation (RRA) analysis was used to integrate those public datasets and identify key genes associated with SLE. The weighted gene coexpression network analysis (WGCNA) was adapted to identify functional modules involved in SLE pathogenesis, and the gene ontology enrichment analysis was utilized to explore their functions. The aberrant expressions of several randomly selected key genes were further validated in SLE patients through quantitative real‐time polymerase chain reaction. Fifteen genome‐wide gene expression datasets were finally included, which involved a total of 1,778 SLE patients and 408 healthy controls. A large number of significantly upregulated or downregulated genes were identified through RRA analysis, and some of those genes were novel SLE gene signatures and their molecular roles in etiology of SLE remained vague. WGCNA further successfully identified six main functional modules involved in the pathogenesis of SLE. The most important functional module involved in SLE included 182 genes and mainly enriched in biological processes, including defense response to virus, interferon signaling pathway, and cytokine‐mediated signaling pathway. This study identifies a number of key genes and functional coexpression modules involved in SLE, which provides deepening insights into the molecular mechanism of SLE at a systems level and also provides some promising therapeutic targets.
- Open Access
- 9 November 2014
- Published by Impact Journals, LLC in Oncotarget
- Vol. 5
Hyperuricemia predicts poor prognosis of patients with cervical cancer
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Cuihong Li1, Yufeng Li2, Na Su2, Qiongna Liu3 and Chunxiang Chai4 1Department of Gynaecology and Obstetrics, Yidu Central Hospital of Weifang, Weifang 261000, China 2Department of Oncology, People’s Hospital of Rizhao, Rizhao 276800, China 3Department of Obstetrics and Gynecology, Huai'an Second People's Hospital and The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an 223001, China 4Department of Rheumatology and Immunology, The Affiliated Hospital of Weifang Medical University, Weifang 261000, China Correspondence to: Chunxiang Chai, email: wyfychai@sina.com Yufeng Li, email: liyufeng0713@163.com Keywords: cervical cancer; uric acid; hyperuricemia; prognosis Received: August 18, 2017 Accepted: December 11, 2017 Published: December 21, 2017 ABSTRACT Previous studies have suggested that hyperuricemia plays an important role in cancer initiation and progression; however, little is known about the role of hyperuricemia in the prognosis of cervical cancer. The aim of this study was to evaluate the association between hyperuricemia and cervical cancer by conducting a retrospective cohort study. 50 cervical cancer patients with hyperuricemia were randomly selected and 1:1 age-matched to 50 normouricemia patients with cervical cancer. We used the Kaplan-Meier survival analysis to determine the overall survival of patients with cervical cancer. Cox regression analysis was also adopted to estimate the role of hyperuricemia in cervical cancer prognosis primarily adjusted by age, tumor stage, status of histological grade, lymph node involvement, and histopathological subtype. The Kaplan-Meier analysis showed patients with hyperuricemia had poorer overall survival than those with normouricemia (P = 0.0086). The univariate and multivariate Cox analyses both showed that hyperuricemia was negatively associated with the overall survival of patients with cervical cancer. Our study suggests that hyperuricemia is related to poor prognosis of patients with cervical cancer.
- 9 November 2014
- Published by Impact Journals, LLC in Oncotarget
- Vol. 5
Open AccessHyperuricemia predicts poor prognosis of patients with cervical cancer
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Cuihong Li1, Yufeng Li2, Na Su2, Qiongna Liu3 and Chunxiang Chai4 1Department of Gynaecology and Obstetrics, Yidu Central Hospital of Weifang, Weifang 261000, China 2Department of Oncology, People’s Hospital of Rizhao, Rizhao 276800, China 3Department of Obstetrics and Gynecology, Huai'an Second People's Hospital and The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an 223001, China 4Department of Rheumatology and Immunology, The Affiliated Hospital of Weifang Medical University, Weifang 261000, China Correspondence to: Chunxiang Chai, email: wyfychai@sina.com Yufeng Li, email: liyufeng0713@163.com Keywords: cervical cancer; uric acid; hyperuricemia; prognosis Received: August 18, 2017 Accepted: December 11, 2017 Published: December 21, 2017 ABSTRACT Previous studies have suggested that hyperuricemia plays an important role in cancer initiation and progression; however, little is known about the role of hyperuricemia in the prognosis of cervical cancer. The aim of this study was to evaluate the association between hyperuricemia and cervical cancer by conducting a retrospective cohort study. 50 cervical cancer patients with hyperuricemia were randomly selected and 1:1 age-matched to 50 normouricemia patients with cervical cancer. We used the Kaplan-Meier survival analysis to determine the overall survival of patients with cervical cancer. Cox regression analysis was also adopted to estimate the role of hyperuricemia in cervical cancer prognosis primarily adjusted by age, tumor stage, status of histological grade, lymph node involvement, and histopathological subtype. The Kaplan-Meier analysis showed patients with hyperuricemia had poorer overall survival than those with normouricemia (P = 0.0086). The univariate and multivariate Cox analyses both showed that hyperuricemia was negatively associated with the overall survival of patients with cervical cancer. Our study suggests that hyperuricemia is related to poor prognosis of patients with cervical cancer.